Cargando…
Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression
Cancer stem-like cells (CSCs) contribute to the high rate of tumor heterogeneity, metastasis, therapeutic resistance, and recurrence. Histone lysine demethylase 4D (KDM4D or JMJD2D) is highly expressed in colon and liver tumors, where it promotes cancer progression; however, the role of JMJD2D in CS...
Autores principales: | Deng, Yuan, Li, Ming, Zhuo, Minghui, Guo, Peng, Chen, Qiang, Mo, Pingli, Li, Wengang, Yu, Chundong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948496/ https://www.ncbi.nlm.nih.gov/pubmed/33434575 http://dx.doi.org/10.1074/jbc.RA120.015335 |
Ejemplares similares
-
Histone Demethylase JMJD2D: A Novel Player in Colorectal and Hepatocellular Cancers
por: Chen, Qiang, et al.
Publicado: (2022) -
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015) -
Demethylase-independent function of JMJD2D as a novel antagonist of p53 to promote Liver Cancer initiation and progression
por: Li, Ming, et al.
Publicado: (2020) -
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014) -
Expression of EpCAM in uveal melanoma
por: Odashiro, Danilo N, et al.
Publicado: (2006)